Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults

Type 2 diabetes affects millions of people worldwide and significantly contributes to morbidity and mortality of those affected by it. Current guidelines recommend individualized treatment regimens following first line metformin therapy. Saxagliptin, a dipeptidyl-peptidase 4 inhibitor, provides a se...

Descripción completa

Detalles Bibliográficos
Autores principales: Minze, Molly G., Klein, Mary S., Terrell, Brian T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738378/
https://www.ncbi.nlm.nih.gov/pubmed/23966808
http://dx.doi.org/10.4137/CMED.S8510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738378/
https://www.ncbi.nlm.nih.gov/pubmed/23966808
http://dx.doi.org/10.4137/CMED.S8510

Ejemplares similares